Epstein Secrets

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai

WHO study, which was not 'blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

eens. USA Today <https://www.usatoday.com/story/news/health/2020/10/22kovid-vaccine-children-clinical-trials-pfizer- cincinnati/3709031001/> (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, aim

used." Bloomberg <https://www.bloomberg.cotn/news/articles/2020-10-22/gilead-virus-therapy-remdesivir-gains- approval-from-fda?srnd-premium> (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

" USA Today <https://www.usatoday.corn/story/news/health/2020/11/30/modema-emergency-fda-authorization- covid-19-vaccine-pfizer/6376336002/> (11/30, Weintraub, 10.31M) reports Modema's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placebo

f it's approved." Bloomberg <https://www.bloomberg.com/news/articles/2020-11-30/modema-plans-to-seek-u-s-eu-clearance-for- covid-19-vaccine> (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Modena shot in August," while the EU, Canada, and

scrutiny "is critical to build trust and confidence" in whichever vaccines emerge. Pfizer Expands Vaccine Trial To Include Teens. USA Today (10/22, Weintraub, 10.31M) reports that "after months of testing its COVID-19 candidate vaccine in adults, Pfizer recently lowered the age of participation to 16, ai

WHO study, which was not `blinded,' meaning that participants and their doctors were aware of which treatments were being used." Bloomberg (10/22, Langreth, 4.73M) reports the approval also allows "Gilead to market the drug and talk about its benefits to doctors, nurses, and patients. That could help so

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster 'conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and

stage testing is complete," while the European Medicines Agency "has signaled it also is open to faster `conditional' clearance." USA Today (11/30, Weintraub, 10.31M) reports Moderna's latest findings "showed that of 196 people in the clinical trial who caught COVID-19, 185 of them had received the placeb

en done is we have been helping to position the vaccine in the warehouses where they can access it immediately if it's approved." Bloomberg (11/30, Langreth, 4.73M) reports the US "reached a deal worth as much as $1.5 billion for 100 million doses of the Moderna shot in August," while the EU, Canada, and